Who Needs the Public?
Executive Summary
In what the company bills as the biggest private financing ever in biotechnology, Tularik raised $60 million at a post-money valuation of $330 million. Although they have been looking to go public for some time now, executives began to reconsider asthe public markets grew shakier in the summer and the fall.